Most Recent
Property listing rivals REA Group and Domain have settled a trade mark lawsuit over an agreement between Domain and the owner of US website realestate.com to redirect Australian traffic to Domain's website.
Westpac has been hit with a class action for allegedly breaching responsible lending laws by providing unsuitable loans, the first of the big four banks to face a class action in the wake of the banking royal commission's scathing final report.
The former chief financial officer for Calvary Health Care has been convicted and sentenced after pleading guilty to making false records that misstated the company's revenue by millions of dollars.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi's challenge to a judge's refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
ASIC has wasted no time in the wake of a critical report from the banking royal commission, reporting a 50 percent spike in investigations into financial services companies since the beginning of the month and promising a number of criminal referrals are on the horizon.
Gladstone Ports has won access to draft expert reports prepared by Clyde & Co in its $100 million class action against the Queensland government owned organisation, with a judge ruling the documents were not privileged despite their not being used in the case.
Liberal Democrat Senator David Leyonhjelm has lost his challenge to a ruling that denied his request for speedy dismissal of a defamation lawsuit by Greens Senator Sarah Hanson-Young on the grounds of Parliamentary privilege.
A judge has recused herself from hearing a lawsuit brought against Norton Rose Fulbright by a former partner, two months after the judge that was initially assigned to the matter dodged a recusal bid by reallocating the case.
The Australian Securities and Investments Commission has appealed a ruling that two Westpac units did not provide personal financial advice as part of a campaign encouraging customers to roll over external superannuation accounts.
Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India's Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.